Exclusive: Pfizer leaning towards abandoning deal with Allergan - source
0
(Reuters) - Drugmaker Pfizer Inc is leaning towards abandoning its $160 billion agreement to buy Allergan Plc in light of the U.S. Treasury's new measures to curb such tax evading deals, a source familiar with the situation said on Tuesday.